https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54339 Wed 28 Feb 2024 15:10:12 AEDT ]]> Acceptability and appropriateness of a clinical pathway for managing anxiety and depression in cancer patients: a mixed methods study of staff perspectives https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40280 Wed 13 Mar 2024 08:58:30 AEDT ]]> Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: the PARAGON trial – ANZGOG 0903 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45582 p = 0.002), cognitive functioning (45 vs 19%: p = 0.021), fatigue (47 vs 19%: p = 0.015) and global health status (42 vs 9%: p = 0.003). Conclusion: Although the objective response rate to anastrozole was relatively low, clinical benefit was observed in 44% of patients with ER/PR positive metastatic endometrial cancer and associated with an improvement in QOL.]]> Wed 02 Nov 2022 10:37:04 AEDT ]]> Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51248 Mon 28 Aug 2023 12:32:43 AEST ]]> The elusive search for success: defining and measuring implementation outcomes in a real-world hospital trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38006 Fri 23 Jul 2021 15:05:40 AEST ]]> Dried Blood Spot Sampling in the Monitoring of Anticancer Therapy for Solid Tumors: A Systematic Review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53882 0.872; correlation coefficient, r = 0.87, P < 0.0001). Conclusions: DBS provides an alternative sampling strategy for the TDM of many anticancer drugs. Further research is required to establish a standardized approach for sampling and processing DBS samples to allow future implementation.]]> Fri 19 Jan 2024 14:22:43 AEDT ]]> Stakeholder perspectives on the impact of COVID-19 on oncology services: a qualitative study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54831 Fri 15 Mar 2024 11:54:29 AEDT ]]> PARAGON: a phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45708 Fri 04 Nov 2022 10:18:27 AEDT ]]>